US 9107887
Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
granted A61KA61K2039/505A61K31/352
Quick answer
US patent 9107887 (Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer) held by Provectus Pharmaceuticals, Inc. expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provectus Pharmaceuticals, Inc.
- Grant date
- Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K31/352, A61K31/365, A61K38/193